Prevalence of Enthesopathies in Adults With X-linked Hypophosphatemia: Analysis of Risk Factors

J Clin Endocrinol Metab. 2022 Jan 1;107(1):e224-e235. doi: 10.1210/clinem/dgab580.

Abstract

Context: Enthesopathies are the determinant of a poor quality of life in adults with X-linked hypophosphatemia (XLH).

Objective: To describe the prevalence of patients with enthesopathies and to identify the risk factors of having enthesopathies.

Methods: Retrospective study in the French Reference Center for Rare Diseases of the Calcium and Phosphate Metabolism between June 2011 and December 2020. Adult XLH patients with full body X-rays performed using the EOS® low-dose radiation system and clinical data collected from medical records. The main outcome measures were demographics, PHEX mutation, conventional treatment, and dental disease with the presence of enthesopathies.

Results: Of the 114 patients included (68% women, mean age 42.2 ± 14.3 years), PHEX mutation was found in 105 patients (94.6%), 86 (77.5%) had been treated during childhood. Enthesopathies (spine and/or pelvis) were present in 67% of the patients (n = 76). Patients with enthesopathies were significantly older (P = .001) and more frequently reported dental disease collected from medical records (P = .03). There was no correlation between the PHEX mutations and the presence of enthesopathies. Sixty-two patients had a radiographic dental examination in a reference center. Severe dental disease (number of missing teeth, number of teeth endodontically treated, alveolar bone loss, and proportion of patients with 5 abscesses or more) was significantly higher in patients with enthesopathies.

Conclusion: Adult XLH patients have a high prevalence of enthesopathies in symptomatic adults patients with XLH seen in a reference center. Age and severe dental disease were significantly associated with the presence of enthesopathies.

Keywords: EOS® imaging; Osteomalacia; X-linked hypophosphatemia (XLH); alveolar bone loss; dental phenotype; enthesopathies.

MeSH terms

  • Adult
  • Enthesopathy / epidemiology*
  • Enthesopathy / genetics
  • Enthesopathy / pathology
  • Familial Hypophosphatemic Rickets / physiopathology*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Mutation*
  • PHEX Phosphate Regulating Neutral Endopeptidase / genetics*
  • Prevalence
  • Prognosis
  • Quality of Life*
  • Retrospective Studies
  • Risk Factors

Substances

  • PHEX Phosphate Regulating Neutral Endopeptidase
  • PHEX protein, human